Avita Medical | 1811094D - Ebitda

Stock Price
1.16
Daily Change
0.01 0.43%
Monthly
4.05%
Yearly
-60.85%
Q1 Forecast
1.19

Avita Medical reported AUD-21.9M in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
Celltrion KRW 374.56B 352.67B Sep/2025
Clinuvel Pharmaceuticals AUD 27.55M 12.65M Jun/2025
Cochlear AUD 292.9M 30.1M Jun/2025
CSL USD 1.96B 1.27B Jun/2025
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Dianthus Therapeutics USD -40.19M 5.36M Sep/2025
Divis Laboratories Ltd INR 8.88B 1.59B Sep/2025
Kangmei Pharma CNY 17.3M 20.56M Jun/2025
Knight Therapeutics CAD 15.51M 3.39M Jun/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Mayne Pharma AUD 20.9M 5.2M Jun/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Nanosonics AUD 11.36M 2.36M Dec/2024
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Organigram Holdings CAD 6.15M 455K Sep/2025
Pacific Edge NZD -13.97M 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
Pharma Mar EUR -1.98M 28.13M Sep/2025
Polynovo AUD 2.86M 1.12M Jun/2024
PYC Therapeutics AUD -24.29M 1.3M Jun/2025
Qiagen NV USD 193.17M 15.81M Sep/2025
Ramsay Health Care AUD 1.11B 84.1M Jun/2025
ResMed USD 547.48M 27.46M Dec/2025
Sartorius EUR 277.4M 30.5M Dec/2025
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Telix Pharmaceuticals AUD 33.24M 6.5M Jun/2025
Tilray USD 8.36M 1.82M Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 531.61M 658.23M Jun/2025